Patents by Inventor Nicholas Matthew Ward

Nicholas Matthew Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IH CHANNEL INHIBITORS FOR THE PROMOTION OF WAKEFULNESS
    Publication number: 20110092486
    Abstract: The present invention relates to use of an Ih channel inhibitor for the manufacture of a medicament for the promotion of wakefulness in a subject in need thereof, in particular, wherein the subject is suffering from excessive sleepiness which may result from a sleep disorder.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 21, 2011
    Inventors: Nicholas Matthew Ward, Gerardus Stephanus Francisc Ruigt, Hugh Marston
  • Drug combination for the treatment of depression and related disorders comprising mirtazapine
    Patent number: 6835728
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: December 28, 2004
    Assignee: Akzo Nobel N.V.
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward
  • Drug combination for the treatment of depression and related disorders comprising mirtazapine
    Publication number: 20030105083
    Abstract: The invention relates to a combination comprising an amount of mirtazapine, or a pharmaceutically acceptable salt or solvate thereof, and an amount of gepirone, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers, whereby the amount of gepirone and the amount of mirtazapine are such that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of depression and related disorders, whereby the invention also provides for a new method of treatment of depression and related disorders.
    Type: Application
    Filed: October 8, 2002
    Publication date: June 5, 2003
    Inventors: John Stuart Andrews, Wilhelmus Drinkenburg, Nicholas Matthew Ward